Ind-Ra assigns Shilpa Medicare’s long term rating at ‘A+’

16 Dec 2020 Evaluate

Credit rating agency-- India Ratings and Research (Ind-Ra) has assigned rating to Shilpa Medicare’s long term rating at ‘A+/Stable’ and short term rating at ‘A+/Stable/A1’ against the existing ratings of long term rating of ‘A (Stable)’ and short term rating of ‘A1’ assigned by ICRA.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

331.30 -2.65 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×